BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 19426696)

  • 1. Ras inhibition attenuates myocardial ischemia-reperfusion injury.
    Pando R; Cheporko Y; Haklai R; Maysel-Auslender S; Keren G; George J; Porat E; Sagie A; Kloog Y; Hochhauser E
    Biochem Pharmacol; 2009 May; 77(10):1593-601. PubMed ID: 19426696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
    Pando R; Barshack I; Raz A; Luboshits G; Haklai R; Maysel-Auslender S; Kloog Y; Keren G; George J
    Cardiovasc Pathol; 2010; 19(2):94-101. PubMed ID: 19144546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    George J; Sack J; Barshack I; Keren P; Goldberg I; Haklai R; Elad-Sfadia G; Kloog Y; Keren G
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):363-8. PubMed ID: 14670932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Ras oncoprotein reduces proliferation of hepatocytes in vitro and in vivo in rats.
    da Silva Morais A; Saliez A; Leclercq I; Horsmans Y; Stärkel P
    Clin Sci (Lond); 2008 Jan; 114(1):73-83. PubMed ID: 17678500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid.
    Reif S; Aeed H; Shilo Y; Reich R; Kloog Y; Kweon YO; Bruck R
    J Hepatol; 2004 Aug; 41(2):235-41. PubMed ID: 15288472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trimetazidine protects isolated rat hearts against ischemia-reperfusion injury in an experimental timing-dependent manner.
    Pantos C; Bescond-Jacquet A; Tzeis S; Paizis I; Mourouzis I; Moraitis P; Malliopoulou V; Politi ED; Karageorgiou H; Varonos D; Cokkinos DV
    Basic Res Cardiol; 2005 Mar; 100(2):154-60. PubMed ID: 15616764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transduction of anti-cell death protein FNK protects isolated rat hearts from myocardial infarction induced by ischemia/reperfusion.
    Arakawa M; Yasutake M; Miyamoto M; Takano T; Asoh S; Ohta S
    Life Sci; 2007 May; 80(22):2076-84. PubMed ID: 17467744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hitting Ras where it counts: Ras antagonism in the basolateral amygdala inhibits long-term fear memory.
    Merino SM; Maren S
    Eur J Neurosci; 2006 Jan; 23(1):196-204. PubMed ID: 16420429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-ischemic administration of landiolol prevents ischemia-reperfusion injury in the rat heart.
    Takahashi Y; Shibata T; Sasaki Y; Hirai H; Takemura S; Minamiyama Y; Sakaguchi M; Suehiro S
    Osaka City Med J; 2007 Jun; 53(1):9-16. PubMed ID: 17867629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ras inhibitor S-trans, trans-farnesylthiosalicylic acid exerts long-lasting neuroprotection in a mouse closed head injury model.
    Shohami E; Yatsiv I; Alexandrovich A; Haklai R; Elad-Sfadia G; Grossman R; Biegon A; Kloog Y
    J Cereb Blood Flow Metab; 2003 Jun; 23(6):728-38. PubMed ID: 12796721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotection from ischemia-reperfusion injury due to Ras-GTPase inhibition is attenuated by glibenclamide in the globally ischemic heart.
    Al-Rashdan I; Canatan H; Al-Maghrebi M; Yousif MH; Khan SA; Benter IF
    Cell Biochem Funct; 2007; 25(4):455-61. PubMed ID: 16850529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary polyphenol quercetin protects rat hearts during reperfusion: enhanced antioxidant capacity with chronic treatment.
    Ikizler M; Erkasap N; Dernek S; Kural T; Kaygisiz Z
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):404-10. PubMed ID: 18065337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sivelestat reduces myocardial ischemia and reperfusion injury in rat hearts even when administered after onset of myocardial ischemia.
    Kambe M; Bessho R; Fujii M; Ochi M; Shimizu K
    Interact Cardiovasc Thorac Surg; 2009 Jun; 8(6):629-34. PubMed ID: 19279053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Ras inhibitor farnesylthiosalicylic acid (Salirasib) disrupts the spatiotemporal localization of active Ras: a potential treatment for cancer.
    Rotblat B; Ehrlich M; Haklai R; Kloog Y
    Methods Enzymol; 2008; 439():467-89. PubMed ID: 18374183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Ras attenuates the course of experimental autoimmune neuritis.
    Kafri M; Kloog Y; Korczyn AD; Ferdman-Aronovich R; Drory V; Katzav A; Wirguin I; Chapman J
    J Neuroimmunol; 2005 Nov; 168(1-2):46-55. PubMed ID: 16154640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
    Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
    Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutritional supplementation with mixed essential amino acids enhances myocyte survival, preserving mitochondrial functional capacity during ischemia-reperfusion injury.
    Scarabelli TM; Pasini E; Stephanou A; Chen-Scarabelli C; Saravolatz L; Knight RA; Latchman DS; Gardin JM
    Am J Cardiol; 2004 Apr; 93(8A):35A-40A. PubMed ID: 15094104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression signature of human cancer cell lines treated with the ras inhibitor salirasib (S-farnesylthiosalicylic acid).
    Blum R; Elkon R; Yaari S; Zundelevich A; Jacob-Hirsch J; Rechavi G; Shamir R; Kloog Y
    Cancer Res; 2007 Apr; 67(7):3320-8. PubMed ID: 17409441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Worsening of long-term myocardial function after successful pharmacological pretreatment with cyclosporine.
    Laudi S; Weimann J; Haschke M; Trump S; Schmitz V; Christians U; Kaisers U; Steudel W
    J Physiol Pharmacol; 2007 Mar; 58(1):19-32. PubMed ID: 17440223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Left ventricular unloading with intra-aortic counter pulsation prior to reperfusion reduces myocardial release of endothelin-1 and decreases infarction size in a porcine ischemia-reperfusion model.
    LeDoux JF; Tamareille S; Felli PR; Amirian J; Smalling RW
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):513-21. PubMed ID: 18814226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.